Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (131-140 of 436) with videos related to

Pageof 44
Sort By:
The New England Journal of Medicine|July 3, 2014
New FDA breakthrough-drug category--implications for patientsJonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
JAMA|August 3, 2021
FDA Regulation and Approval of Medical Devices: 1976-2020Jonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
BMJ (Clinical Research Ed.)|October 25, 2019
Public sector financial support for late stage discovery of new drugs in the United States: cohort studyRahul K Nayak, Jerry Avorn, Aaron S Kesselheim
Health Affairs (Project Hope)|July 13, 2006
The rise and fall of Natrecor for congestive heart failure: implications for drug policyAaron S Kesselheim, Michael A Fischer, Jerry Avorn
JAMA|February 21, 2022
Switching to Over-the-Counter Availability of Rescue Inhalers for AsthmaWilliam B Feldman, Jerry Avorn, Aaron S Kesselheim
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 27, 2002
Pharmaceutical cost containment with reference-based pricing: time for refinementsSebastian Schneeweiss, Malcolm Maclure, Colin Dormuth, et al.
JAMA|August 8, 2013
Who is now responsible for discovering and warning about adverse effects of generic drugs?Aaron S Kesselheim, Michael D Green, Jerry Avorn
Annals of Internal Medicine|December 2, 2014
Burden of changes in generic pill appearanceAaron S Kesselheim, Niteesh K Choudhry, Jerry Avorn
The New England Journal of Medicine|December 7, 2017
Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VIJonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
JAMA Internal Medicine|September 12, 2017
Determinants of Market Exclusivity for Prescription Drugs in the United StatesAaron S Kesselheim, Michael S Sinha, Jerry Avorn
Pageof 44

Showing results (131-140 of 436) with videos related to

Sort By:
Pageof 44
The New England Journal of Medicine|July 3, 2014
New FDA breakthrough-drug category--implications for patientsJonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
JAMA|August 3, 2021
FDA Regulation and Approval of Medical Devices: 1976-2020Jonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
BMJ (Clinical Research Ed.)|October 25, 2019
Public sector financial support for late stage discovery of new drugs in the United States: cohort studyRahul K Nayak, Jerry Avorn, Aaron S Kesselheim
Health Affairs (Project Hope)|July 13, 2006
The rise and fall of Natrecor for congestive heart failure: implications for drug policyAaron S Kesselheim, Michael A Fischer, Jerry Avorn
JAMA|February 21, 2022
Switching to Over-the-Counter Availability of Rescue Inhalers for AsthmaWilliam B Feldman, Jerry Avorn, Aaron S Kesselheim
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 27, 2002
Pharmaceutical cost containment with reference-based pricing: time for refinementsSebastian Schneeweiss, Malcolm Maclure, Colin Dormuth, et al.
JAMA|August 8, 2013
Who is now responsible for discovering and warning about adverse effects of generic drugs?Aaron S Kesselheim, Michael D Green, Jerry Avorn
Annals of Internal Medicine|December 2, 2014
Burden of changes in generic pill appearanceAaron S Kesselheim, Niteesh K Choudhry, Jerry Avorn
The New England Journal of Medicine|December 7, 2017
Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VIJonathan J Darrow, Jerry Avorn, Aaron S Kesselheim
JAMA Internal Medicine|September 12, 2017
Determinants of Market Exclusivity for Prescription Drugs in the United StatesAaron S Kesselheim, Michael S Sinha, Jerry Avorn
Pageof 44